4-Year Results of a Randomized Controlled Trial of Percutaneous Repair Versus Surgery for Mitral Regurgitation
Top Cited Papers
- 2 July 2013
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 62 (4) , 317-328
- https://doi.org/10.1016/j.jacc.2013.04.030
Abstract
No abstract availableKeywords
Funding Information
- St. Jude Medical
- Eli Lilly and Company
- Edwards Lifesciences
- Medtronic
- Boston Scientific Corporation
- American Heart Association
- Abbott Vascular
- Abbott Laboratories
- Cordis
- Gilead Sciences
This publication has 9 references indexed in Scilit:
- Percutaneous Repair or Surgery for Mitral RegurgitationNew England Journal of Medicine, 2011
- Percutaneous Mitral Repair: Patient Selection, Results, and Future DirectionsCurrent Cardiology Reports, 2010
- Predictors of Mitral Regurgitation Recurrence in Patients With Heart Failure Undergoing Mitral Valve AnnuloplastyThe American Journal of Cardiology, 2010
- The EVEREST II Trial: Design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitationAmerican Heart Journal, 2010
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseJournal of the American College of Cardiology, 2006
- ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive SummaryJournal of the American College of Cardiology, 2006
- Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitationThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Mitral RegurgitationCirculation, 2003
- ACC/AHA guidelines for the management of patients with valvular heart diseaseJournal of the American College of Cardiology, 1998